← Eichor
Study identifier: NCT06030388 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women

Condition: Postmenopausal Symptoms · Hot Flashes  ·  Sponsor: Linkoeping University

PhaseNA
Planned participants90
Who can joinFemale, 45 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this randomised controlled trial is to investigate the effects of and compare two modes of physical exercise (strength training and high-intensity aerobic exercise) to unchanged physical activity on vasomotor symptoms (hot flushes) in postmenopausal women. The main question it aims to answer is the effect of 15 weeks of strength training vs high intensity aerobic training vs unchanged physical activity on frequency and severity of hot flushes. Participants will be randomised to: 1. strength training 2. high-intensity aerobic training 3. untreated control group. Researchers will compare strength training, high-intensity aerobic training and untreated control group to see if training can reduce hot flushes.

This description comes directly from the study's public registry record.

Talk to the study team

Anna-Clara Spetz Holm, Ass prof, MD  ·  +46101033130  ·  anna-clara.spetz.holm@liu.se

Always discuss trial participation with your own doctor first.

Locations (2)

Region Kalmar LänKalmar, SwedenRecruiting
Region ÖstergötlandLinköping, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06030388